Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus

類似資料

• Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? ‒ Data from a multicenter registry cohort study in Taiwan
  著者:: Yeh, Yen-Ting, 等
  出版事項: (2017)
• Impact of Atherosclerotic Burden on Long-term Major Adverse Cardiovascular and Cerebrovascular Events
  著者:: Fatma Esin, 等
  出版事項: (2024-12-01)
• Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
  著者:: Li, Yi-Heng, 等
  出版事項: (2020)
• Ten-year predictors of major adverse cardiovascular events in patients without angina
  著者:: Preesha Premsagar, 等
  出版事項: (2023-08-01)
• Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events
  著者:: Mani, Venkatesh, 等
  出版事項: (2009)